United States Insulin Infusion Pumps Market 2031 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

Global insulin infusion pumps market is expected to reach at a high CAGR during the forecast period 2023-2030.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/insulin-infusion-pumps-market?sb

Key Development:

United States: Recent Insulin Infusion Pump Developments

✅ In December 2025, Medtronic's diabetes spinoff MiniMed filed for an IPO, showcasing a broad integrated portfolio of insulin pumps, CGMs and diabetes tech that strengthens its competitive position in automated insulin delivery solutions.

✅ In December 2025, Insulet's enhanced Omnipod 5 Automated Insulin Delivery System received FDA 510(k) clearance for algorithm and target glucose setting improvements that expand customization and support better automated insulin delivery performance.

✅ In February 2025, Tandem Diabetes Care's Control‐IQ+ algorithm for use with pumps such as t:slim X2 and Mobi received expanded FDA clearance for Type 2 diabetes automated insulin delivery, broadening clinical use and access.

✅ In April 2025, Medtronic submitted a 510(k) to the FDA for an interoperable insulin pump (MiniMed 780G ACE) and the SmartGuard iAGC controller algorithm to integrate with Abbott's advanced CGM platform, a key step toward smarter hybrid systems.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=insulin-infusion-pumps-market

Japan: Recent Insulin Infusion Pump Developments

✅ In November 2025, a major global insulin delivery devices market report highlighted growing smart‐pump adoption and automated systems across regions including Japan, signaling increased industry focus on advanced insulin infusion technology.

✅ In November 2025, separate industry coverage indicated rising Japan insulin drug delivery and device demand, with significant market size and adoption supporting future launch and diffusion of pump technologies locally.

✅ In July 2025, Expanding patient access and technology uptake through 2033, reinforcing continued momentum for innovative infusion systems in the country.

✅ In March 2025, Japanese medical coverage noted advanced hybrid closed‐loop and automated insulin delivery systems making notable clinical and care improvements, reflecting ongoing Japanese adoption of next‐generation pump technologies.

Key Players:

=> Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG, Ypsomed AG, F. Hoffmann-La Roche Ltd., Shinmyung Mediyes CO., LTD., Abbott Laboratories, SOOIL Developments Co., Ltd and Smiths Group plc, among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/insulin-infusion-pumps-market?sb

Key Segments:

By Component

Insulin Pumps - Leading segment with 50% share, preferred for continuous insulin delivery and improved glucose control.
Infusion Sets - 30% share, essential for connecting pumps to patients safely and efficiently.
Reservoirs - 20% share, critical for storing insulin and supporting pump functionality.

By Application

Type I Diabetes - 60% share, driven by the need for continuous insulin therapy in insulin-dependent patients.
Type II Diabetes - 40% share, growing due to rising adoption of advanced insulin delivery systems in late-stage type II patients.

By End-User

Hospitals - 35% share, primary point of adoption for clinical monitoring and inpatient therapy.
Specialty Clinics - 25% share, popular for outpatient management and specialized care.
Home Care Settings - 30% share, increasing due to patient preference for at-home insulin therapy and remote monitoring.
Others - 10% share, includes diabetes management centers and research institutions.

By Region

North America - 40% Share
High adoption of advanced insulin pumps, infusion sets, and patient awareness programs.

Europe - 25% Share
Strong preference for home care and specialty clinic adoption; reimbursement policies support growth.

Asia Pacific - 20% Share
Rising diabetes prevalence, increasing healthcare infrastructure, and urbanization drive market expansion.

Latin America - 10% Share
Moderate growth due to rising awareness and improving healthcare facilities.

Middle East & Africa - 5% Share
Emerging market with gradual adoption due to improving healthcare access and diabetes prevalence.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.